DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Jacob S. Leach
CEOJacob S. Leach
Employees
10,300
Employees10,300
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
10,300
Employees10,300

DXCM Key Statistics

Market cap
25.69B
Market cap25.69B
Price-Earnings ratio
36.59
Price-Earnings ratio36.59
Dividend yield
Dividend yield
Average volume
5.72M
Average volume5.72M
High today
$66.67
High today$66.67
Low today
$65.56
Low today$65.56
Open price
$66.34
Open price$66.34
Volume
3.89M
Volume3.89M
52 Week high
$93.25
52 Week high$93.25
52 Week low
$54.11
52 Week low$54.11

Stock Snapshot

The current DexCom(DXCM) stock price is $65.68, with a market capitalization of 25.69B. The stock trades at a price-to-earnings (P/E) ratio of 36.59.

On 2025-12-18, DexCom(DXCM) stock moved within a range of $65.56 to $66.67. With shares now at $65.68, the stock is trading +0.2% above its intraday low and -1.5% below the session's peak.

Trading activity shows a volume of 3.89M, compared to an average daily volume of 5.72M.

Over the past 52 weeks, DexCom(DXCM) stock has traded between a high of $93.25 and a low of $54.11.

Over the past 52 weeks, DexCom(DXCM) stock has traded between a high of $93.25 and a low of $54.11.

DXCM News

TipRanks 11h
Claims Jabil losing share at Dexcom ‘not happening,’ says Raymond James

Jabil’s (JBL) recent stock weakness does not reflect any negative surprises, as earnings, guidance, and management commentary were in line, and claims that Jabi...

Simply Wall St 18h
Dexcom: Valuation Check After Launch of Dexcom Academy for EMEA Healthcare Professionals

DexCom (DXCM) just rolled out Dexcom Academy, a personalised learning platform for healthcare professionals across several EMEA markets, aiming to deepen CGM ex...

Dexcom: Valuation Check After Launch of Dexcom Academy for EMEA Healthcare Professionals
Simply Wall St 4d
Dexcom’s New Clinician Academy: A Subtle Shift in DXCM’s Long‑Term Competitive Moat?

Earlier this month, Dexcom launched Dexcom Academy across several EMEA markets, offering personalised, app-based training for healthcare professionals on its CG...

Dexcom’s New Clinician Academy: A Subtle Shift in DXCM’s Long‑Term Competitive Moat?

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
15.2%
Sell
0%

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.